Social Media and Clinical Trials: Patient-Physician Interactions, Patient-Patient Interactions

Website http://www.onlinecompliancepanel.com/webinar/SocialMediaAndClinicalTrials-501107/OCT-2015-ES | Edit Freely

Category form 1099 due diligence, irs form 1099 penalties, accurate w-9 leads to, accurate form 1099, importance of form w-9, form 1099 accuracy, latest 1099 rules,

Deadline: October 27, 2015 | Date: October 28, 2015

Venue/Country: online Webinar, U.S.A

Updated: 2015-10-08 15:52:51 (GMT+9)

Call For Papers - CFP

Instructor: Mukesh Kumar

Product ID: 501107

Objectives of the Presentation

Best practices for using social media for patient-investigator interactions

Issues related to patient-patient interactions such as "Patientslikeme"

Common ways companies are currently using social media in clinical trials

FDA rules for using social media in clinical trials

Crowd-sourcing, Wiki-creating, data-mining, and other social media practices for clinical trials

Recent trends in FDA enforcement actions involving social media.

Why Should you Attend

Social media could be a great resource to clinical trials by highlighting specific issues, addressing concerns, educating patients and doctors alike, and engaging multiple other groups such as patient support groups, families, public policy makers, politicians, and general public. Social media can be a valuable tool to create awareness about a given trial, disease, patients, and developers. Social media is increasingly used to provide all information about the products being tested, the scientific background, and in general, educating all stakeholders. It makes it easy, accessible, timely and broadly available. While a lot of discussion has been conducted in using social media as a recruitment tool, the impact of social media goes much beyond recruitment of patients but goes into ongoing discussion between patients and investigators, investigators and sponsors, patients with other patients, and sponsor and patients.

This webinar will discuss numerous ways in which social media led patient-patient, patient-investigators, investigator-sponsor, and sponsor-patient interactions and data-mining can be conducted for a better, efficient and productive clinical trial. There are also concerns about maintaining trial integrity, logistical affability, and financial feasibility of using social media in clinical trials. FDA rules and industry practices will be discussed in light of the technological challenges with using social media in clinical trials.

Who can Benefit

Clinical Project Managers

Clinical Research Associates

Clinical Coordinators

Principle Investigators

Compliance Managers

Regulatory Vice Presidents, Directors and Managers

Attorneys - In-house or Outside Counsel

Senior executives of Pharmaceutical and Device Firms

For Registration -

http://www.onlinecompliancepanel.com/webinar/SocialMediaAndClinicalTrials-501107/OCT-2015-ES

Note : Use coupon code 1371 and get 10% off on Registration